Role of leukotriene in patients with asthma-COPD overlap syndrome(ACOS)

Role of leukotriene in patients with asthma-COPD overlap syndrome(ACOS) - Role of leukotriene in ACOS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016135

Enrollment

Registered

2015-04-01

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma-COPD overlap syndrome

Interventions

administration of leukotriene receptor antagonist in patients with asthma-COPD overlap syndrome administration of placebo of leukotriene receptor antagonist in patients with asthma-COPD overlap syndro

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with asthma-COPD overlap syndrome

Exclusion criteria

Exclusion criteria: patients with unstable asthma-COPD overlap syndrome

Design outcomes

Primary

Measure	Time frame
To investigate the role of leukotriene receptor antagonist for respitarory functionas in patients with asthma-COPD overlap syndrome	—

Secondary

Measure	Time frame
To investigate the role of leukotriene receptor antagonist for QOL scores in patients with asthma-COPD overlap syndrome	—

Countries

Japan

Contacts

Public ContactYoshihisa Ishiura

Toyama City Hospital Respiratory Medicine

ishiura@tch.toyama.toyama.jp076-422-1112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026